Mi Ran Yun (Mi R Yun)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Decision Making

Atomic Force Microscopy

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research communications

Yonsei medical journal

EMBO molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young Seob Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of immune-modulatory effects of amivantamab in combination with pembrolizumab in lung and head and neck squamous cell carcinoma. Cancer research communications (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Sun Min Lim, Seong-San Kang, Dong Kwon Kim, Soo-Hwan Lee, Chun-Bong Synn, Sujeong Baek, Seung Min Yang, Yu Jin Han, Mi Hyun Kim, Heekyung Han, Kwangmin Na, Youngtaek Kim, Mi Ran Yun, Seok-Young Kim, Youngseon Byeon, Young S Kim, Jii Bum Lee, Min Hee Hong, Joshua C Curtin, Bharvin Patel, Isabelle Bergiers, Kyoung-Ho Pyo, Byoung Chul Cho
Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma. Cancer research communications 4 (7) (2024)
Eun Ji Lee, Seung Yeon Oh, You Won Lee, Ju Young Kim, Min-Je Kim, Tae Ho Kim, Jii Bum Lee, Min Hee Hong, Sun Min Lim, Anke Baum, Lydia Woelflingseder, Harald Engelhardt, Mark Petronczki, Flavio Solca, Mi Ran Yun, Byoung Chul Cho
Discovery of a Novel Potent EGFR Inhibitor Against EGFR Activating Mutations and On-Target Resistance in NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Seung Yeon Oh, You Won Lee, Eun Ji Lee, Seok-Young Kim, Young Joon Park, Seong Gu Heo, Mi Ra Yu, Min Hee Hong, John O DaSilva, Christopher Daly, Byoung Chul Cho, Sun Min Lim, Mi Ran Yun
Preclinical study of a biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, overcomes MET-driven acquired resistance to EGFR TKIs in EGFR-mutant NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Chun-Bong Synn, Dong Kwon Kim, Seok-Young Kim, Youngseon Byeon, Young Seob Kim, Mi Ran Yun, Ji Min Lee, Wongeun Lee, Eun Ji Lee, Seul Lee, You Won Lee, Doo Jae Lee, Hyun-Woo Kim, Chang Gon Kim, Min Hee Hong, June Dong Park, Sun Min Lim, Kyoung-Ho Pyo
Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor. Yonsei medical journal 63 (1) (2021)
Seok-Young Kim, Sang-Min Kim, Sumin Lim, Ji Yeon Lee, Su-Jin Choi, San-Duk Yang, Mi Ran Yun, Chang Gon Kim, Seo Rin Gu, Chaewon Park, A-Young Park, Sun Min Lim, Seong Gu Heo, HyunKi Kim, Byoung Chul Cho
Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Mi Ran Yun, Hun Mi Choi, You Won Lee, Hyeong Seok Joo, Chae Won Park, Jae Woo Choi, Dong Hwi Kim, Han Na Kang, Kyoung-Ho Pyo, Eun Joo Shin, Hyo Sup Shim, Ross A Soo, James Chih-Hsin Yang, Sung Sook Lee, Hyun Chang, Min Hwan Kim, Min Hee Hong, Hye Ryun Kim, Byoung Chul Cho
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer. EMBO molecular medicine 11 (12) (2019)